|
Video: What is a Stock Split?
|
|
Cellectar Biosciences is a biopharmaceutical company developing compounds for the treatment, diagnosis and imaging of cancer. Co.'s cancer-targeting technology permits selective delivery of a range of agents to cancer cells, including cancer stem cells. By attaching different agents to its phospholipid ether molecules as a cancer-targeting delivery platform, Co. develops product candidates with the potential to treat, diagnose and image a range of cancers. Co. is developing three product candidates: I-124-CLR1404, a cancer-targeting positron emission tomography imaging agent; I-131-CLR1404, a cancer-targeting molecular radiotherapeutic; and CLR1502, a non-radioactive optical imaging agent. According to our CLRBW stock split history records, CLRBW has had 1 split. | |
|
CLRBW (CLRBW) has 1 split in our CLRBW stock split history database. The split for CLRBW took place on March 07, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLRBW owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as CLRBW conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CLRBW stock split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CLRBW shares, starting with a $10,000 purchase of CLRBW, presented on a split-history-adjusted basis factoring in the complete CLRBW stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/14/2014 |
|
End date: |
08/20/2019 |
|
Start price/share: |
$7.20 |
|
End price/share: |
$0.13 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.19% |
|
Average Annual Total Return: |
-56.94% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$180.55 |
|
Years: |
4.76 |
|
|
|
Date |
Ratio |
03/07/2016 | 1 for 10 |
|
|